Fund Holdings — Valence8 US LP

Total Portfolio Value:
$208.23M
Total Bought:
$10.83M
Total Sold:
$25.98M
Net Transaction:
-$15.15M
Notable People:
Valence8 Llc
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Ishares TrMSCI USA Quality Factor
MSCI USA QLT FCT
337,472326,910-10,562$60.51M$58.22M27.96%-$2.29M
Invesco Qqq TrUNIT SER 188,14983,798-4,351$43.02M$42.84M20.57%-$182.8K
Ishares TrMSCI International Quality
MSCI INTL QUALTY
1,026,290990,439-35,851$42.58M$36.77M17.66%-$5.82M
Ishares TrEAFE VALUE ETF399,186404,248+5,062$22.97M$21.21M10.19%-$1.75M
Vanguard Index FdsVALUE ETF96,63097,398+768$16.87M$16.49M7.92%-$379.2K
Select Sector Spdr TrSBI CONS STPLS
ST STR STAPL ETF
165,267166,161+894$13.72M$13.06M6.27%-$655.2K
Ishares TrEXPANDED TECH077,909+77,909$0$7.80M3.75%+$7.80M
Ishares TrMSCI UK ETF NEW
MSCI UK ETF NEW
209,344116,688-92,656$7.83M$3.96M1.90%-$3.88M
Select Sector Spdr TrSBI INT UTILS
ST STR UTIL ETF
51,94052,247+307$4.20M$3.95M1.90%-$241.1K
Ishares IncMSCI Japan ETF
MSCI JAPAN ETF
108,63458,649-49,985$7.77M$3.94M1.89%-$3.84M
Alector Inc14,7080-14,708$68.5K$0—-$68.5K
Apogee Therapeutics Inc5,2400-5,240$307.8K$0—-$307.8K
argenx SEADR(ARGX)9530-953$516.6K$0—-$516.6K
Ascendis Pharma A/SADR(ASND)4,5850-4,585$684.6K$0—-$684.6K
Blueprint Medicines Corp2,6180-2,618$242.2K$0—-$242.2K
Bristol-Myers Squibb Company(BMY)17,7850-17,785$920.2K$0—-$920.2K
Crinetics Pharmaceuticals In6,6840-6,684$341.6K$0—-$341.6K
Eli Lilly and Company(LLY)6330-633$560.8K$0—-$560.8K
Climb Bio, Inc.(CLYM)12,0450-12,045$61.3K$0—-$61.3K
Enanta Pharmaceuticals, Inc.(ENTA)19,9390-19,939$206.6K$0—-$206.6K
Erasca, Inc.(ERAS)46,9230-46,923$128.1K$0—-$128.1K
Indivior Plc57,2930-57,293$564.2K$0—-$564.2K
Insmed Incorporated(INSM)7,8650-7,865$574.1K$0—-$574.1K
Intellia Therapeutics, Inc.(NTLA)13,0200-13,020$267.6K$0—-$267.6K
Janux Therapeutics, Inc.(JANX)7,8570-7,857$356.9K$0—-$356.9K
Jazz Pharmaceuticals plcSHS USD(JAZZ)8,9690-8,969$999.2K$0—-$999.2K
Keros Therapeutics, Inc.(KROS)8,0250-8,025$466.0K$0—-$466.0K
Kezar Life Sciences Inc21,1360-21,136$16.3K$0—-$16.3K
Cypherpunk Technologies Inc.(CYPH)18,5110-18,511$47.6K$0—-$47.6K
Nektar Therapeutics(NKTR)26,1070-26,107$33.9K$0—-$33.9K
Nuvalent Inc4,1150-4,115$421.0K$0—-$421.0K
Relay Therapeutics, Inc.(RLAY)26,2000-26,200$185.5K$0—-$185.5K
Soleno Therapeutics Inc9,7060-9,706$490.1K$0—-$490.1K
Solid Biosciences Inc15,7280-15,728$109.6K$0—-$109.6K
Tyra Biosciences, Inc.(TYRA)13,1880-13,188$310.1K$0—-$310.1K
Ultragenyx Pharmaceutical Inc.(RARE)4,2410-4,241$235.6K$0—-$235.6K
Vaxcyte, Inc.(PCVX)2,4680-2,468$282.0K$0—-$282.0K
Vir Biotechnology, Inc.(VIR)33,6500-33,650$252.0K$0—-$252.0K
Vistagen Therapeutics, Inc.(VTGN)34,3760-34,376$103.5K$0—-$103.5K
Zevra Therapeutics, Inc.(ZVRA)21,5960-21,596$149.9K$0—-$149.9K
Zura Bio LimitedCL A(ZURA)17,4950-17,495$71.0K$0—-$71.0K
Page 1 of 1
Valence8 US LP — 13F Holdings — Q4 2024 | TickerTrail